. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Bromocriptine/pharmacologyBromocriptine/therapeutic useDopamine Agonists/adverse effectsDopamine Agonists/pharmacologyDopamine Agonists/therapeutic useErgot Alkaloids/adverse effectsErgot Alkaloids/pharmacologyErgot Alkaloids/therapeutic useHumansParkinson Disease/drug therapyPergolide/adverse effectsPergolide/pharmacologyPergolide/therapeutic useRandomized Controlled Trials as Topic
Substances： See more » Dopamine AgonistsErgot AlkaloidsPergolideBromocriptine
Year: 2002 PMID： 12211145 DOI： 10.1002/mds.5566
Source DB: PubMed Journal: Mov Disord ISSN： 0885-3185 Impact factor: 10.338